GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | 0.0% | 195 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | -94.0% | 195 | -94.4% | 0.00% | -93.3% |
| Q3 2021 | $134,000 | 0.0% | 3,509 | +4.4% | 0.02% | 0.0% |
| Q2 2021 | $134,000 | +7.2% | 3,360 | -3.9% | 0.02% | 0.0% |
| Q1 2021 | $125,000 | -0.8% | 3,496 | +2.2% | 0.02% | -6.2% |
| Q4 2020 | $126,000 | +2.4% | 3,420 | +4.7% | 0.02% | -5.9% |
| Q3 2020 | $123,000 | +215.4% | 3,265 | +245.5% | 0.02% | +183.3% |
| Q2 2020 | $39,000 | +333.3% | 945 | +316.3% | 0.01% | +500.0% |
| Q3 2017 | $9,000 | -18.2% | 227 | -16.2% | 0.00% | -50.0% |
| Q1 2017 | $11,000 | +266.7% | 271 | +261.3% | 0.00% | +100.0% |
| Q4 2016 | $3,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |